logo BDSP

Base documentaire

  1. Facilitating treatment entry among out-of-treatment injection drug users.

    Article - En anglais


    High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts.

    Moreover, relapse to risk behaviors has been reported among those who initiate risk reduction.

    Substance abuse treatment offers the potential to reduce or eliminate injecting risk behaviors through drug cessation.

    We report on the effectiveness of two intervention strategies in facilitating treatment entry among out-of-treatment IDUs : motivational interviewing (MI), an intervention developed to help individuals resolve their ambivalence about behavior change, and free treatment for 90 days.

    These conditions were compared with an intervention focusing on a hierarchy of safer injecting practices, referred to here as risk reduction (RR), and no free treatment.


    Nearly 200 out-of-treatment IDUs were randomly assigned to one of four experimental conditions :

    • MI/free treatment,

    • MI/no free treatment,

    • RR/free treatment, and RR/no free treatment.

    Regardless of assignment, we assisted anyone desiring treatment by calling to schedule the appointment, providing transportation, and waiving the intake fee.


    Overall, 42% of study participants entered treatment.

    No significant differences were found between Ml and RR ; however, 52% of those assigned free treatment entered compared with 32% for those who had to pay. (...)

    Mots-clés Pascal : SIDA, Virose, Infection, Toxicomanie, Voie intraveineuse, Prévention, Facteur risque, Motivation, Entretien préventif, Traitement substitutif, Chimiothérapie, Homme, Colorado, Etats Unis, Amérique du Nord, Amérique, Immunopathologie, Immunodéficit

    Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Drug addiction, Intravenous administration, Prevention, Risk factor, Motivation, Preventive maintenance, Replacement therapy, Chemotherapy, Human, Colorado, United States, North America, America, Immunopathology, Immune deficiency

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0414233

    Code Inist : 002B05C02D. Création : 22/03/2000.